Detalles de la búsqueda
1.
Efficacy and safety of niraparib as maintenance treatment in older patients (≥â¯70â¯years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial.
Gynecol Oncol;
152(3): 560-567, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30638768
2.
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial.
Lancet Oncol;
19(8): 1117-1125, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30026000
3.
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.
J Gynecol Oncol;
32(5): e82, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34378365
Resultados
1 -
3
de 3
1
Próxima >
>>